FTC Takes Legal Action to Halt Amgen's Acquisition of Horizon Therapeutics Amid Monopoly Concerns, Applied Digital Secures Major AI Customer, Etsy Faces Price Target Revision
- May 16th, 2023
- 835 views
The Federal Trade Commission (FTC) has taken action to prevent the acquisition of Horizon Therapeutics plc (Nasdaq: HZNP) by the biopharmaceutical giant, Amgen Inc. (Nasdaq: AMGN). In its efforts to block the transaction, the FTC has filed a lawsuit in federal court, expressing concerns that the acquisition would allow Amgen to utilize rebates on its existing blockbuster drugs to exert pressure on insurance companies and pharmacy benefit managers (PBMs). The goal would be to favor Horizon's two monopoly products—Tepezza, a treatment for thyroid eye disease, and Krystexxa, which addresses chronic refractory gout. Notably, both of these treatments currently face no competition in the pharmaceutical marketplace.
Following the FTC's announcement, the stock market has responded accordingly. On Tuesday, $AMGN 's shares are currently trading at $228.04, experiencing a decrease of $5.49 (-2.35%) and $HZNP 's shares at $95.92, reflecting a decline of $16.33 (-14.55%).
In other news, Applied Digital Corporation (Nasdaq: APLD) has made an exciting announcement regarding its recently launched AI Cloud Service. Through its wholly-owned subsidiary Sai Computing, the company has secured its first major AI customer, signing an agreement valued at up to $180 million over a 24-month period. As a result of this positive news, $APLD is currently trading at $5.57, representing an increase of $2.16 (63.10%).
Additionally, Morgan Stanley has revised the price target for Etsy, Inc. (Nasdaq: ETSY), lowering it from $79 to $74. $ETSY 's shares are trading at $92.85, reflecting a decrease of $5.00 (-5.11%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease
November 18th, 2026November 18th, 2026Treasury, IRS Issue Final Rules to Help Hardworking Americans Build a Financially Secure Retirement
November 17th, 2026November 17th, 2026What Wall Street Expects From NVIDIA, Disney, and Elbit Systems
November 15th, 2026




Member Login